chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 49.0
Sex: F
Vaccine: COVID19
Symptoms: Lymphadenopathy
Clinical narrative: Swollen lymph nodes under left arm; This is a spontaneous report from a contactable consumer, the patient. A 49-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8737) via an unspecified route of administration in the left arm on 08Apr2021 at 11:00 (at the age of 49-years-old) as a single dose for COVID-19 immunisation. The patient medical history was reported as none. The patient had previous allergy to codeine. The patient did not receive any other medications within 2 weeks of vaccination. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6207) via an unspecified route of administration in the left arm on 20Mar2021 at 11:45 as single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 10Apr2021 at 08:00, the patient experienced swollen lymph nodes under left arm. The patient did not receive any treatment for the event. The adverse event did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the event swollen lymph nodes was recovering.   No follow-up attempts are needed. No further information is expected.
Age: 29.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Chills, Dehydration, Headache, Myalgia
Clinical narrative: Pain at injection site; abnormal dehydration; nausea; vomiting; fever of 100.8; headaches; muscle aches; chills; This is a spontaneous report from a contactable consumer, the patient. A 29-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 09Apr2021(at the age of 29-year-old) as a single dose for COVID-19 immunisation. Medical history included mild asthma. Concomitant medications included intrauterine contraceptive device (MANUFACTURER UNKNOWN) implant from an unknown date and for an unknown indication. The patient previously took first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 09Apr2021 at 11:00 (at the age of 29-year-old) as a single dose for COVID-19 immunisation. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 09Apr2021 at 14:00, the patient experienced pain at injection site(vaccination site pain), abnormal dehydration, nausea, vomiting, fever of 100.8, headaches, muscle aches and chills. The patient did not receive any treatment for the reported events. On an unknown date, the patient underwent lab tests which included body temperature and the result was 100.8 (unit unknown). The clinical outcome of the events  pain at injection site, abnormal dehydration, nausea, vomiting, fever of 100.8, headaches, muscle aches and chills were resolving at the time of this report.   No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Age: 29.0
Sex: F
Vaccine: COVID19
Symptoms: Nausea, Pyrexia, Vaccination site pain, Vomiting
Clinical narrative: Pain at injection site; abnormal dehydration; nausea; vomiting; fever of 100.8; headaches; muscle aches; chills; This is a spontaneous report from a contactable consumer, the patient. A 29-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 09Apr2021(at the age of 29-year-old) as a single dose for COVID-19 immunisation. Medical history included mild asthma. Concomitant medications included intrauterine contraceptive device (MANUFACTURER UNKNOWN) implant from an unknown date and for an unknown indication. The patient previously took first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 09Apr2021 at 11:00 (at the age of 29-year-old) as a single dose for COVID-19 immunisation. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 09Apr2021 at 14:00, the patient experienced pain at injection site(vaccination site pain), abnormal dehydration, nausea, vomiting, fever of 100.8, headaches, muscle aches and chills. The patient did not receive any treatment for the reported events. On an unknown date, the patient underwent lab tests which included body temperature and the result was 100.8 (unit unknown). The clinical outcome of the events  pain at injection site, abnormal dehydration, nausea, vomiting, fever of 100.8, headaches, muscle aches and chills were resolving at the time of this report.   No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: Hypokinesia, Inflammation, Musculoskeletal stiffness, Pain, Rash
Clinical narrative: right hand shoulder had inflammation; was unable to move my hand; extreme pain with any movement of my hand/horrible pain while moving my arm; stiffness and horrible pain while moving my arm.; Very tiny rash on my right risk; This is a spontaneous report from a contactable consumer, the patient. A 53-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP6955) via an unspecified route of administration in the left arm on 27Mar2021 at 14:00 (at the age of 53-year-old) as a single dose for COVID-19 immunisation. Medical history included diabetes, high cholesterol, asthma, neck and shoulder pain and environmental allergies. Concomitant medications included metformin (MANUFACTURER UNKNOWN), pantoprazole (MANUFACTURER UNKNOWN), simvastatin (MANUFACTURER UNKNOWN) and lisinopril (MANUFACTURER UNKNOWN), all for unknown indications on unknown dates. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 29Mar2021 at 11:00, Monday morning, the patient's right hand shoulder had inflammation and she was unable to move her hand. There was an extreme pain with any movement of hand. The patient also reported that she had a sore neck (right side) and sore shoulder (right side) for weeks before the vaccine. She slept on her right side Sunday night and Monday morning woke up with this stiffness and horrible pain while moving her arm. She was much better after physical therapy on Tuesday 30Mar2021. The patient went to orthopedic surgeon on 01Apr2021 (thu) and doctor gave a cortisone shot on her right hand. She was much better now with her right shoulder and didn't had any pain while moving it. She also had a "very tiny rash on my right risk" which was gone now. The patient reported that she hopes she can get her scheduled second shot on 17Apr2021. She also reported that she doesn't know if the shot triggered this inflammation and pain. Events resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of reported events and included treatment with physical therapy on Tuesday, 30Mar2021 and Cortisone shot by Orthopedic Surgeon on 01Apr2021. The clinical outcome of the events right hand shoulder had inflammation, unable to move her hand, extreme pain with any movement of hand, stiffness and horrible pain while moving her arm and very tiny rash on right risk was recovered on an unknown date in Apr2021.   No follow-up attempts are needed. No further information is expected.
Age: 39.0
Sex: F
Vaccine: COVID19
Symptoms: Herpes zoster, Oral herpes
Clinical narrative: shingles on my face; Shingles on my face and in my mouth; This is a spontaneous report from a contactable consumer, the patient. A 39-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP7534), via an unspecified route of administration in the left arm on 22Mar2021 at 17:00 (at the age of 39-years-old), as a single dose for COVID-19 immunisation. Medical history was not reported. The patient was allergic to penicillin. Concomitant medications included amlodipine (MANUFACTURER UNKNOWN) from an unknown date for an unknown indication. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6203), via an unspecified route of administration in the left arm on 01Mar2021 at 17:00 (at the age of 39-years-old), as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 05Apr2021, the patient experienced "shingles on my face and in my mouth". The events resulted in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were taken as a result of the events shingles on my face and in my mouth which included treatment with anti-viral drug from an unknown date. The clinical outcome of the events shingles on my face and in my mouth were not resolved at the time of reporting.   No follow-up attempts are needed. No further information is expected.
Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Chills, Headache, Hyperhidrosis, Myalgia
Clinical narrative: Headache - moderate; Nausea- moderate; Injection site soreness; Fever-severe; Chills severe; Muscle aches- severe; Joint aches- severe; Severe sweating; Thirst drenched; This is a spontaneous report from a contactable consumer, the patient. A 46-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0162) via an unspecified route of administration in the arm left on 09Apr2021 at 14:00 (at the age of 46-year-old) as a single dose for COVID-19 immunisation. Medical history included depression and anxiety. The patient had allergies to penicillin. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included duloxetine hydrochloride (CYMBALTA), buspirone (MANUFACTURER UNKNOWN) and ethinylestradiol, norethisterone (NOTREL) all were from an unknown date for an unknown indication. The patient previously took the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER2613) via an unspecified route of administration in the arm left on 19Mar2021 at 15:00 (at the age of 46-year-old) as a single dose for COVID-19 immunisation. On 09Apr2021 at 18:00, within 4 hours after the vaccination, the patient experienced moderate headache, moderate nausea and injection site soreness. On 09Apr2021 at 01:00, within 11 hours after the vaccination, the patient experienced severe fever, chills, muscle aches, joint aches, continued moderate headache and nausea, severe sweating and thirst drenched. It was reported that the patient's pajamas in sweat 3X sheets and pillow sweated out. At 24 hours post-dose, fever was mild to moderate, chills mild to moderate, mild headache and nausea, severe muscle and joint aches and fatigue. Therapeutic measures were taken as a result of the events included treatment with 1000 mg Tylenol every 6 hours from 09Apr2021 at 23:00. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events headache, nausea, injection site soreness, severe fever, chills, muscle aches, joint aches, severe sweating and thirst drenched were recovering at the time of the report.  No follow-up attempts are needed. No further information is expected.
Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: Nausea, Pyrexia, Thirst decreased, Vaccination site pain
Clinical narrative: Headache - moderate; Nausea- moderate; Injection site soreness; Fever-severe; Chills severe; Muscle aches- severe; Joint aches- severe; Severe sweating; Thirst drenched; This is a spontaneous report from a contactable consumer, the patient. A 46-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0162) via an unspecified route of administration in the arm left on 09Apr2021 at 14:00 (at the age of 46-year-old) as a single dose for COVID-19 immunisation. Medical history included depression and anxiety. The patient had allergies to penicillin. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included duloxetine hydrochloride (CYMBALTA), buspirone (MANUFACTURER UNKNOWN) and ethinylestradiol, norethisterone (NOTREL) all were from an unknown date for an unknown indication. The patient previously took the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER2613) via an unspecified route of administration in the arm left on 19Mar2021 at 15:00 (at the age of 46-year-old) as a single dose for COVID-19 immunisation. On 09Apr2021 at 18:00, within 4 hours after the vaccination, the patient experienced moderate headache, moderate nausea and injection site soreness. On 09Apr2021 at 01:00, within 11 hours after the vaccination, the patient experienced severe fever, chills, muscle aches, joint aches, continued moderate headache and nausea, severe sweating and thirst drenched. It was reported that the patient's pajamas in sweat 3X sheets and pillow sweated out. At 24 hours post-dose, fever was mild to moderate, chills mild to moderate, mild headache and nausea, severe muscle and joint aches and fatigue. Therapeutic measures were taken as a result of the events included treatment with 1000 mg Tylenol every 6 hours from 09Apr2021 at 23:00. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events headache, nausea, injection site soreness, severe fever, chills, muscle aches, joint aches, severe sweating and thirst drenched were recovering at the time of the report.  No follow-up attempts are needed. No further information is expected.
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Pain in extremity
Clinical narrative: Sore arm; Mild Headache; This is a spontaneous report from a contactable nurse. A 52-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE;Lot Number: EW0 151) via an unspecified route of administration in the left arm on 09Apr2021 at 12:30 (at the age of 52-years-old) as a single dose for COVID-19 immunisation. The patient did not receive any medication within two weeks of vaccination. The patient previously took Demerol, Darvocet (Darvicette), Morphine, Vancomycin, Reglan and experienced drug allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 10Apr2021, the patient experienced sore arm and mild headache. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events sore arm and mild headache was resolved on 10Apr2021.   No follow-up attempts are needed. No further information is expected.
Sex: M
Vaccine: COVID19
Symptoms: Headache, Nausea
Clinical narrative: Headache; nausea; This is a spontaneous report from a non-contactable consumer, the patient. A male patient of unknown age received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0153) via an unspecified route of administration in the left arm on an unknown date in Apr2021 at 11:45 as a single dose for COVID-19 immunisation. Medical history included hypertension. The patient had no known allergies to medications, food, or other products. Concomitant medication was reported as yes (unspecified). Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 10Apr2021 at 09:00, the patient experienced headache and nausea. The patient did not receive any treatment for the events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events headache and nausea were resolving at the time of this report.   No follow-up attempts are possible. No further information is expected.
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Swelling
Clinical narrative: Golf ball size swelling to left of the right antecubital fossa; This is a spontaneous report from a contactable consumer, the patient. A 63-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ep7533) via an unspecified route of administration in the right arm on 07Apr2021 at 16:15 (at the age of 63-year-old) as a single dose for COVID-19 immunisation. Medical history included hypertension, atrial fibrillation, overweight, smoker and allergy to PC (penicillin). Concomitant medications included naltrexone hydrochloride, bupropion hydrochloride (CONTRAVE), acetylsalicylic acid (ASA) and multivitamins (MANUFACTURER UNKNOWN) for unknown indication from unknown date. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 10Apr2021 the patient experienced golf ball size swelling to left of the right antecubital fossa. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. No therapeutic measures were taken as a result of the events. The clinical outcome of the event swelling to left of the right antecubital fossa was not recovered.  No follow-up attempts are needed. No further information is expected.
Age: 34.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Bruxism, Chills, Decreased appetite, Insomnia
Clinical narrative: Chills; terrible migraine; achey entire body; couldn't sleep; arm tender; clenched jaw for several hours; lack of energy; couldn't relax; no appetite; This is a spontaneous report from a contactable consumer, the patient. A 34-year-old non pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: Ew0151), via an unspecified route of administration in the left arm on 09Apr2021 at 10:00 (at the age of 34 years old) as single dose for COVID-19 immunisation. The patient had no reported medical history. Concomitant medications included prenatal & OTC allergy meds from an unknown date and for unknown indication. The patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: En6208), via an unspecified route of administration in the left arm on 19MAr2021 at 11:15 as single dose for COVID-19 immunisation. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, patient was not diagnosed with COVID-19; Since the vaccination, patient had not been tested for COVID-19. On 09Apr2021 at 21:00, patient experienced chills, terrible migraine, ache entire body, couldn't sleep, arm tender, clenched jaw for several hours couldn't relax, lack of energy and no appetite. The patient did not receive any treatment for the reported events. The adverse event did not result in doctor or other healthcare professional office or clinic visit and emergency room or department or urgent care. The clinical outcome of the event chills, terrible migraine, ache entire body, couldn't sleep, arm tender, clenched jaw for several hours couldn't relax, lack of energy and no appetite were not recovered at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 34.0
Sex: F
Vaccine: COVID19
Symptoms: Migraine, Pain, Pain in extremity
Clinical narrative: Chills; terrible migraine; achey entire body; couldn't sleep; arm tender; clenched jaw for several hours; lack of energy; couldn't relax; no appetite; This is a spontaneous report from a contactable consumer, the patient. A 34-year-old non pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: Ew0151), via an unspecified route of administration in the left arm on 09Apr2021 at 10:00 (at the age of 34 years old) as single dose for COVID-19 immunisation. The patient had no reported medical history. Concomitant medications included prenatal & OTC allergy meds from an unknown date and for unknown indication. The patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: En6208), via an unspecified route of administration in the left arm on 19MAr2021 at 11:15 as single dose for COVID-19 immunisation. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, patient was not diagnosed with COVID-19; Since the vaccination, patient had not been tested for COVID-19. On 09Apr2021 at 21:00, patient experienced chills, terrible migraine, ache entire body, couldn't sleep, arm tender, clenched jaw for several hours couldn't relax, lack of energy and no appetite. The patient did not receive any treatment for the reported events. The adverse event did not result in doctor or other healthcare professional office or clinic visit and emergency room or department or urgent care. The clinical outcome of the event chills, terrible migraine, ache entire body, couldn't sleep, arm tender, clenched jaw for several hours couldn't relax, lack of energy and no appetite were not recovered at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 45.0
Sex: M
Vaccine: COVID19
Symptoms: Herpes zoster
Clinical narrative: About 15-16 days after the vaccine, I developed a severe case of shingles.; This is a spontaneous report from a contactable consumer, the patient. A 45-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EL9263) via an unspecified route of administration in the left arm on 01Mar2021 at 15:45 (at the age of 45-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. The patient had no known allergies to food, medicine or other products. Concomitant medications taken within two weeks prior to vaccination included bupropion hydrochloride (manufacturer: WELLBUTRIN XL), losartan (MANUFACTURER UNKNOWN), quetiapine fumarate (manufacturer: SEROQUEL), lurasidone hydrochloride (manufacturer: LATUDA) and alprazolam (manufacturer: XANAX) all from unknown date for unknown indication. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 16Mar2021, about 15-16 days after the vaccine, the patient developed a severe case of shingles. The event resulted in doctor or other healthcare professional office/clinic visit. The event resulted in emergency room/department or urgent care. Therapeutic measures were taken as a result of shingles and included treatment with Antiviral medication, steroid, pain medication. The clinical outcome of the event about 15-16 days after the vaccine, the patient developed a severe case of shingles was resolved with sequelae on an unknown date in 2021.   No follow-up attempts are needed. No further information is expected.
Age: 37.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Dry mouth, Feeling abnormal, Food poisoning, Hangover
Clinical narrative: Shooting pains in legs and arms; Restless legs; Severe dry mouth; constant thirst; Chills; Fever; Headache; Vertigo; Fog feeling; Almost felt like a bad hangover mixed with foodpoisoning; Almost felt like a bad hangover mixed with foodpoisoning; This is a spontaneous report from a non-contactable consumer, the patient. A 37-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: Er8737) via an unspecified route of administration in the left arm on 01Apr2021 at 09:15 (at the age of 37-years-old) as a single dose for COVID-19 immunisation. Medical history included asthma. The patient had no allergies to medications, food, or other products. The patient received nature made daily vitamin for women within two weeks of vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: Unknown) via an unspecified route of administration on an unspecified date as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 01Apr2021 at 19:00, the patient experienced shooting pains in legs and arms, restless legs, severe dry mouth, constant thirst, chills, fever, headache, vertigo, in a fog feeling and almost felt like a bad hangover mixed with food poisoning. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. No therapeutic measures were taken as a result of the events. The clinical outcome of the events shooting pains in legs and arms, restless legs, severe dry mouth, constant thirst, chills, fever, headache, vertigo, fog feeling, almost felt like a bad hangover mixed with food poisoning were recovered on an unknown date in Apr2021.  No follow-up attempts are possible. No further information is expected.
Age: 37.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Pain, Pyrexia, Restless legs syndrome, Thirst
Clinical narrative: Shooting pains in legs and arms; Restless legs; Severe dry mouth; constant thirst; Chills; Fever; Headache; Vertigo; Fog feeling; Almost felt like a bad hangover mixed with foodpoisoning; Almost felt like a bad hangover mixed with foodpoisoning; This is a spontaneous report from a non-contactable consumer, the patient. A 37-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: Er8737) via an unspecified route of administration in the left arm on 01Apr2021 at 09:15 (at the age of 37-years-old) as a single dose for COVID-19 immunisation. Medical history included asthma. The patient had no allergies to medications, food, or other products. The patient received nature made daily vitamin for women within two weeks of vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: Unknown) via an unspecified route of administration on an unspecified date as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 01Apr2021 at 19:00, the patient experienced shooting pains in legs and arms, restless legs, severe dry mouth, constant thirst, chills, fever, headache, vertigo, in a fog feeling and almost felt like a bad hangover mixed with food poisoning. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. No therapeutic measures were taken as a result of the events. The clinical outcome of the events shooting pains in legs and arms, restless legs, severe dry mouth, constant thirst, chills, fever, headache, vertigo, fog feeling, almost felt like a bad hangover mixed with food poisoning were recovered on an unknown date in Apr2021.  No follow-up attempts are possible. No further information is expected.
Age: 37.0
Sex: F
Vaccine: COVID19
Symptoms: Vertigo
Clinical narrative: Shooting pains in legs and arms; Restless legs; Severe dry mouth; constant thirst; Chills; Fever; Headache; Vertigo; Fog feeling; Almost felt like a bad hangover mixed with foodpoisoning; Almost felt like a bad hangover mixed with foodpoisoning; This is a spontaneous report from a non-contactable consumer, the patient. A 37-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: Er8737) via an unspecified route of administration in the left arm on 01Apr2021 at 09:15 (at the age of 37-years-old) as a single dose for COVID-19 immunisation. Medical history included asthma. The patient had no allergies to medications, food, or other products. The patient received nature made daily vitamin for women within two weeks of vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: Unknown) via an unspecified route of administration on an unspecified date as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 01Apr2021 at 19:00, the patient experienced shooting pains in legs and arms, restless legs, severe dry mouth, constant thirst, chills, fever, headache, vertigo, in a fog feeling and almost felt like a bad hangover mixed with food poisoning. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. No therapeutic measures were taken as a result of the events. The clinical outcome of the events shooting pains in legs and arms, restless legs, severe dry mouth, constant thirst, chills, fever, headache, vertigo, fog feeling, almost felt like a bad hangover mixed with food poisoning were recovered on an unknown date in Apr2021.  No follow-up attempts are possible. No further information is expected.
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Chills, Headache, Influenza like illness, Pyrexia
Clinical narrative: flu like symptoms; Headache; fever; Joint pain; chills; This is a spontaneous report from a contactable consumer, the patient. A 53-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 05Apr2021 (at the age of 53-year-old) as a single dose for COVID-19 immunisation. Medical history was not reported. The patient had no allergies to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 08Apr2021, the patient experienced flu like symptoms, headache, chills fever and joint pain. Therapeutic measures were not taken as a result of the events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcomes of the events flu like symptoms, headache, chills fever and joint pain was resolving at the time of this report.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 24.0
Sex: F
Vaccine: COVID19
Symptoms: Hypoaesthesia, Paraesthesia
Clinical narrative: Pins and needles; numbness in left side of face; This is a spontaneous report from a contactable consumer, the patient. A 24-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6205) via an unspecified route of administration in the arm left on 09Apr2021 at 10:15 (at the age of 24-year-old) as a single dose for COVID-19 immunisation. The patient's concomitant medications included mirabegron (MYRBETRIQ), ethinylestradiol, norethisterone (PIRMELLA) and fluconazole (DIFLUCAN) from unknown start date for unknown indications. The patient's medical history was not reported. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 09Apr2021 at 20:00, the patient experienced pins and needles and numbness in left side of face. The events resulted in emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. The clinical outcomes of the events pins and needles and numbness in left side of face was not recovered at the time of reporting.   No follow-up attempts are needed. No further information is expected.
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Breast pain
Clinical narrative: Severe, stabbing and piercing feeling on the left upper side of my right breast.; This is a spontaneous report from a contactable consumer, the patient. A 69-year-old female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, lot number: unknown) via an unspecified route of administration on 02Apr2021 at 08:45 (at the age of 69-years-old) as a single dose for COVID-19 immunisation. Medical history included acid reflux (esophageal). The patient had no known allergies. Concomitant medications included famotidine once a day (MANUFACTURER UNKNOWN), cultrelle (MANUFACTURER UNKNOWN), flaxs (MANUFACTURER UNKNOWN) and calcium carbonate, colecalciferol (CALTRATE) from unknown date for unknown indication within two weeks of vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 03Apr2021 at 10:00, the patient experienced severe, stabbing and piercing feeling on the left upper side of her right breast. After that feeling, there was pain that lasted for 4 days. As the days passed on, the pain had diminished. The pain had scared the patient that she thought of going to the ER. No therapeutic measures were taken as a result of the reported events. The adverse event did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the event severe, stabbing and piercing feeling on the left upper side of her right breast was recovered on 07Apr2021.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Platelet count, Platelet count decreased
Clinical narrative: I had regular bloodwork done on February 18th. I had an appt on the first of April to get my results back.  My platelets had dropped to 134,000 and they are normally over 150,000; This is a spontaneous report from a contactable consumer, the patient. A 71-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6199) via an unspecified route of administration in the arm left on 08Mar2021 at 13:45 (at the age of 71-years-old) as a single dose for COVID-19 immunisation. The patient had unspecified medical history. The patient received unspecified concomitant medications and also received shingrix (MANUFACTURER UNKNOWN) on 20Feb2021 in left arm for unknown indication. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient received other vaccine within four weeks prior to the vaccination. On 18Feb, the patient had regular bloodwork done. She had an appt on the first of April to get her results back.  Her platelets had dropped to 134,000 and they were normally over 150,000. On an unknown date, the patient underwent platelet count and the result was her platelets had dropped to 134,000 and they are normally over 150,000. Therapeutic measures were not taken as a result of the event. The adverse event did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the event platelet count decreased was unknown at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 42.0
Sex: F
Vaccine: COVID19
Symptoms: Lymph node pain, Lymphadenopathy
Clinical narrative: Sore lymph node on left collarbone; Swollen lymph node on left collarbone; This is a spontaneous report from a contactable consumer, the patient. A 42-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0150) via an unspecified route of administration in the left arm on 05Apr2021 at 14:00 (at the age of 42-years-old) as a single dose for COVID-19 immunisation. Medical history included blood pressure high. Patient had no known allergies to medications, food or other products. Concomitant medications included lisinopril dihydrate (LISINOPRIL), venlafaxine hydrochloride (EFFEXOR), norgestimate (ORTHO CYCLEN) for unknown indication, from unknown dates and unknown if ongoing. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 07Apr2021 the patient experienced sore lymph node on left collarbone and swollen lymph node on left collarbone. No therapeutic measures were not taken as a result of reported events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the event sore lymph node and swollen lymph node on left collarbone was not recovered at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Pruritus, Rash, Rash papular
Clinical narrative: a few circular, shiny, raised patches of skin on the injected arm; whole body itching and My fingertips itching; a few circular, shiny, raised patches of skin on the injected arm; This is a spontaneous report from a contactable consumer, the patient. A 51-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER2613) via an unspecified route of administration in the left arm on 03Apr2021 (at the age of 51-years-old), as a single dose for COVID-19 immunisation. Medical history included year round environmental allergy and asthma. The patient received unspecified medication within two weeks of vaccination. The patient previously took first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6199) via an unspecified route of administration in the left arm on 13Mar2021 (at the age of 51-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination the patient not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 07Apr2021, after the third day of the second dose, the patient developed a few circular, shiny, raised patches of skin on the injected arm and whole body itching and fingertips were itching. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were taken as a result of the reported events which included treatment with benadryl. The clinical outcome of the event few circular, shiny, raised patches of skin on the injected arm and whole body itching and fingertips were itching was not recovered at the time of report.   No follow-up attempts are needed. No further information is expected.
Age: 27.0
Sex: M
Vaccine: COVID19
Symptoms: Body temperature, Fatigue, Laziness, Pain in extremity, Pyrexia
Clinical narrative: Had a temperature the whole day; Feeling fatigue; Laziness; Pain started in the left arm; This is a spontaneous report from a contactable consumer, the patient. A 27-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, lot number: EN6207) via an unspecified route of administration in the left arm on 09Apr2021 at 13:45 (at the age of 27-years-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. The patient had no known allergies. The patient did not receive any other medications in two weeks of vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 09Apr2021 at 18:00, the patient experienced pain started in the left arm. On 09Apr2021 at 22:00, the patient experienced fatigue/laziness. On 10Apr2021 the next day, the patient experienced temperature the whole day. Therapeutic measures were taken as a result of the event fever which included treatment with Dolo-650 mg tablet. The clinical outcome of the events pain started in the left arm, fatigue, laziness and temperature was recovering at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Dysgeusia, Headache
Clinical narrative: Strong metallic taste in mouth 5 minutes after dose; Strong headache about 20 minutes after dose; This is a spontaneous report from a contactable consumer, the patient. A 50-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8732) via an unspecified route of administration in the left arm on 25Mar2021, at 15:00 (at the age of 50-years-old) as a single dose for COVID-19 immunisation. Medical history included pre-diabetic, obesity and high blood pressure. The patient had no allergies to medications, food or other products. Concomitant medications included montelukast sodium (SINGULAIR), sertraline hydrochloride (ZOLOFT) and irbesartan (MANUFACTURER UNKNOWN) all for unknown indicatio, from unknown dates and unknown if ongoing. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 25Mar2021 at 15:15, the patient experienced strong metallic taste in mouth 5 minutes after dose and strong headache about 20 minutes after dose. No therapeutic measures were taken as a result of reported adverse events. The clinical outcome of the events strong metallic taste in mouth 5 minutes after dose and strong headache about 20 minutes after dose was resolved on an unknown date in 2021.   No follow-up attempts are needed. No further information is expected.
Age: 24.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site swelling
Clinical narrative: Swelling/redness at the injection site; Swelling/redness at the injection site.Did not have any redness for the first week. It was about an inch wide and has since gotten to be about twoinches.; This is a spontaneous report from a contactable consumer, the patient. A 24-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8734), via an unspecified route of administration in the right arm on 01Apr2021 at 12:15 (at the age of 24-years-old), as a single dose for COVID-19 immunisation. Medical history was not reported. The patient did not have any allergies to medications, food or other products. Concomitant medications included somatropin (NORDITROPINE) from unknown date for unspecified indication. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 09Apr2021, a week later, the patient noticed swelling/redness at the injection site. The patient did not have any redness for the first week. It was about an inch wide and has since gotten to be about two inches. Therapeutic measures were not taken as a result of the events. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. The clinical outcome of the events swelling/redness at the injection site, did not have any redness for the first week, it was about an inch wide and has since gotten to be about two inches were unknown at the time of reporting.   No follow-up attempts are needed. No further information is expected.
Age: 36.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness
Clinical narrative: Dizziness; This is a spontaneous report from a contactable consumer, the patient. A 36-year-old female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Ew0162) via an unspecified route of administration in the arm left on 10Apr2021 at 08:30 (at the age of 36-year-old) as a single dose for COVID-19 immunisation. Medical history included penicillin allergy. Pregnant at the time of vaccination was reported as unknown. Concomitant medications included estradiol (ESTRADIOLO), progesterone (MANUFACTURER UNKNOWN) and chlorpropamide (CHLOMIDE) for unknown indication from an unknown date. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Er8727) via an unspecified route of administration in the arm left on 20Mar2021 at 08:45 (at the age of 36-year-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 10Apr2021 at 22:30 the patient experienced Dizziness. The event did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the event. The clinical outcome of the event Dizziness was recovering at the time of this report.   No follow-up attempts are needed. No further information is expected.